angiotensin II inhibitors (Weill Cornell Medical College/Cornell Center for Technology Enterprise & Commercialization)

N/A

Report date: 2025/03/14 16:54:39
NME

Base Information

Drug Nameangiotensin II inhibitors (Weill Cornell Medical College/Cornell Center for Technology Enterprise & Commercialization)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II receptor antagonists
TargetsAngiotensin II receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWeill Medical College of Cornell University
China Registration ClassN/A

Develop Information

Active CompaniesWeill Medical College of Cornell UniversityCornell University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A